Dec 8, 2018
In this special edition of the MDedge Daily News, MDedge
Hematology Editor, Mary Ellen Schneider, and Nick Andrews present
some of the most important news with full comments from researchers
- CLL resistance mechanism to venetoclax identified.
- Rivaroxaban may reduce VTE risk in cancer patients.
- New treatments promise sickle cell "cure" for all
- Gut bacteria influence HCT outcomes.